1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
FRAX (TM) and the assessment of fracture probability in men and women from the UK
(
- Contribution to journal › Article
- 2007
-
Mark
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries - an economic evaluation based on the fracture intervention trial
(
- Contribution to journal › Article
- 2006
-
Mark
The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective
(
- Contribution to journal › Article
- 2005
-
Mark
Requirements for DXA for the management of osteoporosis in Europe
(
- Contribution to journal › Article
- 2002
-
Mark
Uncertain future of trials in osteoporosis
(
- Contribution to journal › Scientific review
- 1999
-
Mark
No increase in fracture incidence in patients treated for thyrotoxicosis in Malmo during 1970-74. A 20-year population-based follow-up
(
- Contribution to journal › Article
- 1998
-
Mark
Increased incidence of fractures in middle-aged and elderly men with low intakes of phosphorus and zinc
(
- Contribution to journal › Article
- 1997
-
Mark
1 What is the impact of osteoporosis?
(
- Contribution to journal › Article
- 1988
-
Mark
Changes in incidence and prevalence of vertebral fractures during 30 years
(
- Contribution to journal › Article